APA (7th ed.) Citation

JH, S., HJ, L., DY, S., JE, P., CH, A., SY, P., . . . SH, K. (2023). Honokiol inhibits epithelial-mesenchymal transition and hepatic fibrosis via activation of Ecadherin/GSK3β/JNK and inhibition of AKT/ERK/p38/β-catenin/TMPRSS4 signaling axis. Phytotherapy research : PTR, 37(9), 4092. https://doi.org/10.1002/ptr.7871

Chicago Style (17th ed.) Citation

JH, Seo, et al. "Honokiol Inhibits Epithelial-mesenchymal Transition and Hepatic Fibrosis via Activation of Ecadherin/GSK3β/JNK and Inhibition of AKT/ERK/p38/β-catenin/TMPRSS4 Signaling Axis." Phytotherapy Research : PTR 37, no. 9 (2023): 4092. https://doi.org/10.1002/ptr.7871.

MLA (9th ed.) Citation

JH, Seo, et al. "Honokiol Inhibits Epithelial-mesenchymal Transition and Hepatic Fibrosis via Activation of Ecadherin/GSK3β/JNK and Inhibition of AKT/ERK/p38/β-catenin/TMPRSS4 Signaling Axis." Phytotherapy Research : PTR, vol. 37, no. 9, 2023, p. 4092, https://doi.org/10.1002/ptr.7871.